Tuesday, September 30, 2014 3:01:39 PM
On September 25, 2014, the Company filed a lawsuit in the United States District Court for the District of Colorado against Stephen G. Calandrella (“Calandrella”) in order to recover the profits Calandrella obtained through short-swing trading in the Company’s common stock. Such profits, which the Company believes Calandrella obtained unlawfully, are rightfully owed to the Company. The Company brought the lawsuit against Calandrella under section 16(b) of the Exchange Act.
According to the complaint filed in federal court, Calandrella failed to report all of his holdings of the Company’s common stock to the Company. Instead, while a principal stockholder, he engaged in a series of purchases and sales of the Company’s common stock within a six-month period in violation of federal securities law. Pursuant to section 16(b) of the Exchange Act, the complaint demands that Calandrella return to the Company his profits on such trades with interest. The lawsuit is captioned Advanced Cannabis Solutions, Inc. v. Stephen G. Calandrella, Colorado District Court Civil Action No. 14-CV-02649.
As previously announced, on March 27, 2014, the Securities and Exchange Commission temporarily suspended trading in CANN common stock. The Securities and Exchange Commission’s stated reason for the stop trading order was that “[t]here are questions regarding whether certain undisclosed affiliates and shareholders of Advanced Cannabis common stock engaged in an unlawful public distribution of securities.”
As a result of that suspension, the Company was delisted from the OTC markets. In attempting to get relisted on the OTC Bulletin Board, the Company learned that Calandrella’s conduct was a subject of the regulatory action that led to the temporary suspension and subsequent delisting of ACS stock. The Company began an investigation into Calendrella¹s activities. The Company¹s investigation is ongoing.
The Company continues to work with all applicable agencies to seek active quotation of its common stock.
Recent CANN News
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/09/2024 09:00:27 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/21/2023 01:30:11 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 11/14/2023 09:30:23 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/23/2023 08:30:18 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/14/2023 07:51:24 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/07/2023 09:00:27 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/02/2023 08:33:03 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 07/07/2023 08:30:37 PM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM